

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 6.73408736 |
| 2 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 5.05455447 |
| 3 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.80063838 |
| 4 | thioester biosynthetic process (GO:0035384) | 4.52468106 |
| 5 | acyl-CoA biosynthetic process (GO:0071616) | 4.52468106 |
| 6 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.50486009 |
| 7 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.44861851 |
| 8 | very long-chain fatty acid metabolic process (GO:0000038) | 4.02352051 |
| 9 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.87867198 |
| 10 | axon ensheathment in central nervous system (GO:0032291) | 3.82861311 |
| 11 | central nervous system myelination (GO:0022010) | 3.82861311 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79105042 |
| 13 | regulation of activation of Janus kinase activity (GO:0010533) | 3.56654435 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.54948170 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 3.54948170 |
| 16 | regulation of memory T cell differentiation (GO:0043380) | 3.51929930 |
| 17 | cholesterol biosynthetic process (GO:0006695) | 3.50473749 |
| 18 | low-density lipoprotein particle remodeling (GO:0034374) | 3.38001200 |
| 19 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.34031524 |
| 20 | acyl-CoA metabolic process (GO:0006637) | 3.33264253 |
| 21 | thioester metabolic process (GO:0035383) | 3.33264253 |
| 22 | response to methylmercury (GO:0051597) | 3.21606168 |
| 23 | cytidine metabolic process (GO:0046087) | 3.21054797 |
| 24 | cytidine catabolic process (GO:0006216) | 3.21054797 |
| 25 | cytidine deamination (GO:0009972) | 3.21054797 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 3.21005351 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.21005351 |
| 28 | angiotensin maturation (GO:0002003) | 3.20545909 |
| 29 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.20364141 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.17306108 |
| 31 | sterol biosynthetic process (GO:0016126) | 3.11809749 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.11760756 |
| 33 | epoxygenase P450 pathway (GO:0019373) | 3.11191884 |
| 34 | regulation of sequestering of triglyceride (GO:0010889) | 3.10521568 |
| 35 | triglyceride biosynthetic process (GO:0019432) | 3.04445073 |
| 36 | fatty acid beta-oxidation (GO:0006635) | 3.02832534 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.02385875 |
| 38 | branched-chain amino acid catabolic process (GO:0009083) | 3.02136397 |
| 39 | drug catabolic process (GO:0042737) | 3.01712891 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 3.00815857 |
| 41 | acylglycerol biosynthetic process (GO:0046463) | 3.00798911 |
| 42 | neutral lipid biosynthetic process (GO:0046460) | 3.00798911 |
| 43 | fatty acid catabolic process (GO:0009062) | 3.00350983 |
| 44 | ethanol metabolic process (GO:0006067) | 2.98698030 |
| 45 | lipid oxidation (GO:0034440) | 2.95743654 |
| 46 | amyloid precursor protein catabolic process (GO:0042987) | 2.95642008 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93069583 |
| 48 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.93058695 |
| 49 | short-chain fatty acid metabolic process (GO:0046459) | 2.90203912 |
| 50 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.88115286 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 2.87717016 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 2.87245404 |
| 53 | fatty acid oxidation (GO:0019395) | 2.86425627 |
| 54 | signal peptide processing (GO:0006465) | 2.85318629 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83988737 |
| 56 | reverse cholesterol transport (GO:0043691) | 2.82291309 |
| 57 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.81883685 |
| 58 | fructose metabolic process (GO:0006000) | 2.78679598 |
| 59 | uronic acid metabolic process (GO:0006063) | 2.75141235 |
| 60 | glucuronate metabolic process (GO:0019585) | 2.75141235 |
| 61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74530488 |
| 62 | negative regulation of cell killing (GO:0031342) | 2.74530488 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 2.73486311 |
| 64 | exogenous drug catabolic process (GO:0042738) | 2.73450534 |
| 65 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.73120197 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 2.72364033 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 2.72364033 |
| 68 | macromolecular complex remodeling (GO:0034367) | 2.72364033 |
| 69 | nucleotide transmembrane transport (GO:1901679) | 2.71574674 |
| 70 | monocarboxylic acid catabolic process (GO:0072329) | 2.69680083 |
| 71 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.68922526 |
| 72 | drug metabolic process (GO:0017144) | 2.67515385 |
| 73 | platelet dense granule organization (GO:0060155) | 2.66593576 |
| 74 | cellular glucuronidation (GO:0052695) | 2.65392908 |
| 75 | high-density lipoprotein particle remodeling (GO:0034375) | 2.64657939 |
| 76 | cholesterol efflux (GO:0033344) | 2.64407417 |
| 77 | ethanol oxidation (GO:0006069) | 2.63474739 |
| 78 | cellular response to interleukin-15 (GO:0071350) | 2.63442728 |
| 79 | positive regulation of steroid metabolic process (GO:0045940) | 2.62743034 |
| 80 | xenobiotic catabolic process (GO:0042178) | 2.61431037 |
| 81 | amyloid precursor protein metabolic process (GO:0042982) | 2.60712755 |
| 82 | sulfur amino acid catabolic process (GO:0000098) | 2.59620090 |
| 83 | glyoxylate metabolic process (GO:0046487) | 2.59442379 |
| 84 | DNA deamination (GO:0045006) | 2.59423751 |
| 85 | acetyl-CoA metabolic process (GO:0006084) | 2.59303117 |
| 86 | coenzyme catabolic process (GO:0009109) | 2.59002329 |
| 87 | regulation of cholesterol metabolic process (GO:0090181) | 2.58318324 |
| 88 | branched-chain amino acid metabolic process (GO:0009081) | 2.57950331 |
| 89 | phospholipid efflux (GO:0033700) | 2.56951942 |
| 90 | plasma lipoprotein particle organization (GO:0071827) | 2.56019977 |
| 91 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.55417190 |
| 92 | ketone body metabolic process (GO:1902224) | 2.53719703 |
| 93 | response to lipoprotein particle (GO:0055094) | 2.53646281 |
| 94 | regulation of cellular extravasation (GO:0002691) | 2.53596815 |
| 95 | bile acid metabolic process (GO:0008206) | 2.53494320 |
| 96 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.53175459 |
| 97 | valine metabolic process (GO:0006573) | 2.53085799 |
| 98 | positive regulation of interleukin-17 production (GO:0032740) | 2.52815604 |
| 99 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.51470854 |
| 100 | alkaloid metabolic process (GO:0009820) | 2.50548894 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 2.48388455 |
| 102 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.46369293 |
| 103 | regulation of triglyceride metabolic process (GO:0090207) | 2.45979763 |
| 104 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.45650867 |
| 105 | triglyceride metabolic process (GO:0006641) | 2.44896802 |
| 106 | negative regulation of acute inflammatory response (GO:0002674) | 2.44450314 |
| 107 | positive regulation of defense response to virus by host (GO:0002230) | 2.43928648 |
| 108 | bile acid biosynthetic process (GO:0006699) | 2.43730680 |
| 109 | aromatic amino acid family catabolic process (GO:0009074) | 2.43518108 |
| 110 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42961324 |
| 111 | opsonization (GO:0008228) | 2.41860909 |
| 112 | primary alcohol metabolic process (GO:0034308) | 2.41442693 |
| 113 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.40711105 |
| 114 | biotin metabolic process (GO:0006768) | 2.40271005 |
| 115 | cellular ketone body metabolic process (GO:0046950) | 2.40063899 |
| 116 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.39451692 |
| 117 | neutrophil activation (GO:0042119) | 2.38870208 |
| 118 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.38824782 |
| 119 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.37644069 |
| 120 | negative regulation of lipase activity (GO:0060192) | 2.37621097 |
| 121 | protein-lipid complex subunit organization (GO:0071825) | 2.37050404 |
| 122 | cofactor catabolic process (GO:0051187) | 2.36341723 |
| 123 | cellular response to cholesterol (GO:0071397) | 2.35899768 |
| 124 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.35212287 |
| 125 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.34977685 |
| 126 | regulation of beta-amyloid formation (GO:1902003) | 2.34838369 |
| 127 | response to dietary excess (GO:0002021) | 2.33959132 |
| 128 | phenylpropanoid metabolic process (GO:0009698) | 2.33742274 |
| 129 | L-serine transport (GO:0015825) | 2.33411280 |
| 130 | ER overload response (GO:0006983) | 2.31625136 |
| 131 | linoleic acid metabolic process (GO:0043651) | 2.30727988 |
| 132 | primary alcohol catabolic process (GO:0034310) | 2.30554596 |
| 133 | vitamin biosynthetic process (GO:0009110) | 2.30159346 |
| 134 | tyrosine metabolic process (GO:0006570) | 2.29641389 |
| 135 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.28385612 |
| 136 | regulation of lipoprotein metabolic process (GO:0050746) | 2.27928191 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.27452577 |
| 138 | hormone catabolic process (GO:0042447) | 2.27289613 |
| 139 | bile acid and bile salt transport (GO:0015721) | 2.26943621 |
| 140 | acylglycerol metabolic process (GO:0006639) | 2.25806126 |
| 141 | coenzyme A metabolic process (GO:0015936) | 2.25481446 |
| 142 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.25341007 |
| 143 | regulation of cell killing (GO:0031341) | 2.24920768 |
| 144 | succinate metabolic process (GO:0006105) | 2.24766521 |
| 145 | cholesterol metabolic process (GO:0008203) | 2.24479847 |
| 146 | neutral lipid metabolic process (GO:0006638) | 2.23842064 |
| 147 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.23579545 |
| 148 | protein carboxylation (GO:0018214) | 2.23579545 |
| 149 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.22992238 |
| 150 | aldehyde catabolic process (GO:0046185) | 2.22959494 |
| 151 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.22090248 |
| 152 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.21033600 |
| 153 | positive regulation of icosanoid secretion (GO:0032305) | 2.20864845 |
| 154 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.20396700 |
| 155 | granulocyte activation (GO:0036230) | 2.18594145 |
| 156 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.18578734 |
| 157 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.18222365 |
| 158 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.16868788 |
| 159 | positive regulation of cell killing (GO:0031343) | 2.16340528 |
| 160 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.15111324 |
| 161 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.14071218 |
| 162 | positive regulation of fatty acid transport (GO:2000193) | 2.13100407 |
| 163 | B cell mediated immunity (GO:0019724) | 2.12960586 |
| 164 | cellular response to zinc ion (GO:0071294) | 2.12768728 |
| 165 | adenosine metabolic process (GO:0046085) | 2.12677645 |
| 166 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.11765024 |
| 167 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.11225617 |
| 168 | negative regulation of interleukin-12 production (GO:0032695) | 2.10140771 |
| 169 | positive regulation of prostaglandin secretion (GO:0032308) | 2.09939236 |
| 170 | reactive oxygen species biosynthetic process (GO:1903409) | 2.09384629 |
| 171 | L-fucose catabolic process (GO:0042355) | 2.07818118 |
| 172 | fucose catabolic process (GO:0019317) | 2.07818118 |
| 173 | L-fucose metabolic process (GO:0042354) | 2.07818118 |
| 174 | response to interleukin-15 (GO:0070672) | 2.07483668 |
| 175 | positive regulation of respiratory burst (GO:0060267) | 2.06799061 |
| 176 | positive regulation of T cell mediated immunity (GO:0002711) | 2.04956047 |
| 177 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.04376058 |
| 178 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.04267608 |
| 179 | regulation of T-helper 1 type immune response (GO:0002825) | 2.03213275 |
| 180 | response to interferon-beta (GO:0035456) | 2.03072830 |
| 181 | NADH metabolic process (GO:0006734) | 2.01382182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.83573834 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.56145640 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.35540884 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.12677099 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09289377 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.78509647 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.73066416 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.67495200 |
| 9 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.46496480 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.22893881 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.18464083 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.15132563 |
| 13 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.11989113 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.05705820 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82595894 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81136563 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79054163 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78692491 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73618619 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67690272 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63901950 |
| 22 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.61705796 |
| 23 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.59620616 |
| 24 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.59620616 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.58184868 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55860473 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.54621234 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46767189 |
| 29 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41250795 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.40775977 |
| 31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40775892 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39772759 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38123246 |
| 34 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.38012302 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37487485 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36246931 |
| 37 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.36114584 |
| 38 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34942875 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34146440 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32022150 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29840493 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29216634 |
| 43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27596122 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.25097552 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24007285 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23907787 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22414888 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19643344 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18788917 |
| 50 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18151871 |
| 51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.17653526 |
| 52 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.16765961 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16178981 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14601252 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13999517 |
| 56 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13110842 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12045808 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.11849692 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11001091 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10891423 |
| 61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10705840 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10676615 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09334719 |
| 64 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.09170311 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.09054985 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08962277 |
| 67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08929628 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07392115 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06917644 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06287450 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05712431 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05622696 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05235919 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05187726 |
| 75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04306071 |
| 76 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.04246323 |
| 77 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03652432 |
| 78 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03652432 |
| 79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03138574 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.02397359 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01044138 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00839678 |
| 83 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00221292 |
| 84 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99470575 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99021336 |
| 86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.98398209 |
| 87 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98253474 |
| 88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98169548 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98092565 |
| 90 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98059633 |
| 91 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.97829862 |
| 92 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.97666891 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97636223 |
| 94 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.97104464 |
| 95 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96585168 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96339325 |
| 97 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95511108 |
| 98 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94664737 |
| 99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93579615 |
| 100 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93204820 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93129507 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92698915 |
| 103 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92646468 |
| 104 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92185315 |
| 105 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91707173 |
| 106 | NCOR_22424771_ChIP-Seq_293T_Human | 0.90293260 |
| 107 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.89780997 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89685301 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.89651375 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89650158 |
| 111 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89191068 |
| 112 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87998258 |
| 113 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87127345 |
| 114 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86893732 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86846770 |
| 116 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86839187 |
| 117 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85688058 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85546312 |
| 119 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.85437170 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85225065 |
| 121 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.85042035 |
| 122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84905272 |
| 123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84761401 |
| 124 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84101095 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84013350 |
| 126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83685165 |
| 127 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83358363 |
| 128 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82578617 |
| 129 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82507974 |
| 130 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82507974 |
| 131 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.82390296 |
| 132 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82379897 |
| 133 | AR_20517297_ChIP-Seq_VCAP_Human | 0.82094370 |
| 134 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81699083 |
| 135 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81275190 |
| 136 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81275190 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80756519 |
| 138 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.80109532 |
| 139 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78835205 |
| 140 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78809516 |
| 141 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78470007 |
| 142 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.76686808 |
| 143 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.74616953 |
| 144 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74595367 |
| 145 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74046297 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.72919345 |
| 147 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72897059 |
| 148 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72438309 |
| 149 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.71910680 |
| 150 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.71324819 |
| 151 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71225321 |
| 152 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.69719694 |
| 153 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69635729 |
| 154 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.69454856 |
| 155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69025013 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68251309 |
| 157 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.68236292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.32558333 |
| 2 | MP0005365_abnormal_bile_salt | 3.00388987 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.99532491 |
| 4 | MP0003690_abnormal_glial_cell | 2.88140455 |
| 5 | MP0009840_abnormal_foam_cell | 2.71595589 |
| 6 | MP0003011_delayed_dark_adaptation | 2.68715342 |
| 7 | MP0005671_abnormal_response_to | 2.66915518 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.42017207 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.38731915 |
| 10 | MP0003724_increased_susceptibility_to | 2.37205543 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.27814052 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.23305995 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.21893192 |
| 14 | MP0005360_urolithiasis | 2.19324686 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.12811137 |
| 16 | MP0003195_calcinosis | 2.10479127 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.09353891 |
| 18 | MP0000920_abnormal_myelination | 2.06229642 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.97232155 |
| 20 | MP0003329_amyloid_beta_deposits | 1.91121022 |
| 21 | MP0005083_abnormal_biliary_tract | 1.88824230 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.86909921 |
| 23 | MP0005332_abnormal_amino_acid | 1.86058052 |
| 24 | MP0000604_amyloidosis | 1.83341588 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.81868557 |
| 26 | MP0002254_reproductive_system_inflammat | 1.81236844 |
| 27 | MP0005387_immune_system_phenotype | 1.78906185 |
| 28 | MP0001790_abnormal_immune_system | 1.78906185 |
| 29 | MP0003866_abnormal_defecation | 1.75184098 |
| 30 | MP0001800_abnormal_humoral_immune | 1.74559541 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.72431058 |
| 32 | MP0005670_abnormal_white_adipose | 1.72401746 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.68452956 |
| 34 | MP0002723_abnormal_immune_serum | 1.65899922 |
| 35 | MP0004130_abnormal_muscle_cell | 1.62107981 |
| 36 | MP0000685_abnormal_immune_system | 1.56776179 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.51094421 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.49403789 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.48683149 |
| 40 | MP0001661_extended_life_span | 1.48059966 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44014298 |
| 42 | MP0003303_peritoneal_inflammation | 1.41680853 |
| 43 | MP0003186_abnormal_redox_activity | 1.39046220 |
| 44 | MP0001819_abnormal_immune_cell | 1.37571720 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.37276448 |
| 46 | MP0002971_abnormal_brown_adipose | 1.36413477 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.35804711 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 1.35679409 |
| 49 | MP0003075_altered_response_to | 1.35431071 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.35283524 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.34665239 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.34371248 |
| 53 | MP0002295_abnormal_pulmonary_circulatio | 1.34016919 |
| 54 | MP0003279_aneurysm | 1.31422000 |
| 55 | MP0005166_decreased_susceptibility_to | 1.31292219 |
| 56 | MP0000343_altered_response_to | 1.30743634 |
| 57 | MP0009697_abnormal_copulation | 1.29947588 |
| 58 | MP0005535_abnormal_body_temperature | 1.29592972 |
| 59 | MP0002822_catalepsy | 1.26969701 |
| 60 | MP0002419_abnormal_innate_immunity | 1.26030546 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.24764192 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.24357617 |
| 63 | MP0000609_abnormal_liver_physiology | 1.22237362 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.22178047 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.21788725 |
| 66 | MP0009384_cardiac_valve_regurgitation | 1.18757257 |
| 67 | MP0001765_abnormal_ion_homeostasis | 1.18455504 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.18325271 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.18221003 |
| 70 | MP0005164_abnormal_response_to | 1.15794402 |
| 71 | MP0003436_decreased_susceptibility_to | 1.14394227 |
| 72 | MP0009764_decreased_sensitivity_to | 1.14091627 |
| 73 | MP0003634_abnormal_glial_cell | 1.14005618 |
| 74 | MP0005666_abnormal_adipose_tissue | 1.13499652 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.13497977 |
| 76 | MP0004381_abnormal_hair_follicle | 1.13090257 |
| 77 | MP0006082_CNS_inflammation | 1.11157835 |
| 78 | MP0002876_abnormal_thyroid_physiology | 1.08505322 |
| 79 | MP0001853_heart_inflammation | 1.07886750 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 1.05733250 |
| 81 | MP0009785_altered_susceptibility_to | 1.04943917 |
| 82 | MP0000538_abnormal_urinary_bladder | 1.04925916 |
| 83 | MP0001764_abnormal_homeostasis | 1.04586298 |
| 84 | MP0003950_abnormal_plasma_membrane | 1.04428507 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 1.04407344 |
| 86 | MP0009643_abnormal_urine_homeostasis | 1.03750634 |
| 87 | MP0002090_abnormal_vision | 1.03685687 |
| 88 | MP0005451_abnormal_body_composition | 1.03054788 |
| 89 | MP0005646_abnormal_pituitary_gland | 1.02974322 |
| 90 | MP0005408_hypopigmentation | 1.01898658 |
| 91 | MP0001756_abnormal_urination | 1.00996851 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 1.00631594 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.97285983 |
| 94 | MP0005334_abnormal_fat_pad | 0.96588451 |
| 95 | MP0003646_muscle_fatigue | 0.96303873 |
| 96 | MP0005171_absent_coat_pigmentation | 0.96051388 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.95068485 |
| 98 | MP0002796_impaired_skin_barrier | 0.92641182 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.92122407 |
| 100 | MP0003633_abnormal_nervous_system | 0.91982094 |
| 101 | MP0002132_abnormal_respiratory_system | 0.91647699 |
| 102 | MP0005310_abnormal_salivary_gland | 0.91284199 |
| 103 | MP0004043_abnormal_pH_regulation | 0.90242256 |
| 104 | MP0000716_abnormal_immune_system | 0.90143443 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.89735807 |
| 106 | MP0001905_abnormal_dopamine_level | 0.89165516 |
| 107 | MP0008872_abnormal_physiological_respon | 0.89071324 |
| 108 | MP0002933_joint_inflammation | 0.88987500 |
| 109 | MP0002405_respiratory_system_inflammati | 0.88953304 |
| 110 | MP0001984_abnormal_olfaction | 0.88332921 |
| 111 | MP0008469_abnormal_protein_level | 0.88161615 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.88061014 |
| 113 | MP0001542_abnormal_bone_strength | 0.87769777 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.86931400 |
| 115 | MP0002909_abnormal_adrenal_gland | 0.86791600 |
| 116 | MP0004019_abnormal_vitamin_homeostasis | 0.86202375 |
| 117 | MP0003763_abnormal_thymus_physiology | 0.85857917 |
| 118 | MP0004883_abnormal_blood_vessel | 0.85503201 |
| 119 | MP0000516_abnormal_urinary_system | 0.84970383 |
| 120 | MP0005367_renal/urinary_system_phenotyp | 0.84970383 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.84939798 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.84808865 |
| 123 | MP0002006_tumorigenesis | 0.83333769 |
| 124 | MP0001873_stomach_inflammation | 0.83279352 |
| 125 | MP0001851_eye_inflammation | 0.83197919 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.81725792 |
| 127 | MP0006036_abnormal_mitochondrial_physio | 0.81481442 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.80988651 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.80808367 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.78898533 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.78525766 |
| 132 | MP0005025_abnormal_response_to | 0.78432242 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.77564093 |
| 134 | MP0004147_increased_porphyrin_level | 0.77345354 |
| 135 | MP0003172_abnormal_lysosome_physiology | 0.76924008 |
| 136 | MP0001501_abnormal_sleep_pattern | 0.75676181 |
| 137 | MP0000372_irregular_coat_pigmentation | 0.75071047 |
| 138 | MP0005448_abnormal_energy_balance | 0.75046981 |
| 139 | MP0004142_abnormal_muscle_tone | 0.73939083 |
| 140 | MP0000689_abnormal_spleen_morphology | 0.73578740 |
| 141 | MP0003252_abnormal_bile_duct | 0.73556086 |
| 142 | MP0003045_fibrosis | 0.73020271 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.72695248 |
| 144 | MP0009763_increased_sensitivity_to | 0.71921473 |
| 145 | MP0005000_abnormal_immune_tolerance | 0.71184113 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.69694950 |
| 147 | MP0003868_abnormal_feces_composition | 0.69650033 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.68423340 |
| 149 | MP0001881_abnormal_mammary_gland | 0.68241963 |
| 150 | MP0003631_nervous_system_phenotype | 0.67935273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 4.01515880 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.75551405 |
| 3 | Hypoglycemic coma (HP:0001325) | 3.71469242 |
| 4 | Xanthomatosis (HP:0000991) | 3.60953628 |
| 5 | Stomatitis (HP:0010280) | 3.43586768 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 3.21511515 |
| 7 | Myositis (HP:0100614) | 3.05803863 |
| 8 | Optic neuritis (HP:0100653) | 3.05092195 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.05092195 |
| 10 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01468462 |
| 11 | Orchitis (HP:0100796) | 3.00487458 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.00111843 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 2.98821308 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 2.97907290 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 2.95950266 |
| 16 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.95878729 |
| 17 | Ketosis (HP:0001946) | 2.89721147 |
| 18 | Hepatic necrosis (HP:0002605) | 2.87002096 |
| 19 | Ketoacidosis (HP:0001993) | 2.85321169 |
| 20 | Parakeratosis (HP:0001036) | 2.83498734 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.78288977 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.78288977 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.78288977 |
| 24 | Acute encephalopathy (HP:0006846) | 2.73620239 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 2.73372244 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 2.71114693 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 2.69764902 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.69764902 |
| 29 | Dicarboxylic aciduria (HP:0003215) | 2.66266389 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66266389 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62930411 |
| 32 | Acute necrotizing encephalopathy (HP:0006965) | 2.61933352 |
| 33 | Hypoglycemic seizures (HP:0002173) | 2.57934688 |
| 34 | Cerebral edema (HP:0002181) | 2.52919225 |
| 35 | Hyperglycinuria (HP:0003108) | 2.52798317 |
| 36 | Chronic diarrhea (HP:0002028) | 2.52737404 |
| 37 | Amyloidosis (HP:0011034) | 2.52644610 |
| 38 | Abnormality of the axillary hair (HP:0100134) | 2.44019282 |
| 39 | Abnormality of secondary sexual hair (HP:0009888) | 2.44019282 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.43384809 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 2.42871791 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.41413568 |
| 43 | Deep venous thrombosis (HP:0002625) | 2.35882672 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34805320 |
| 45 | Hepatocellular necrosis (HP:0001404) | 2.34174825 |
| 46 | Axonal loss (HP:0003447) | 2.33996745 |
| 47 | Hyperammonemia (HP:0001987) | 2.32907345 |
| 48 | Hepatosplenomegaly (HP:0001433) | 2.32186236 |
| 49 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.30742533 |
| 50 | Complement deficiency (HP:0004431) | 2.30708778 |
| 51 | Malnutrition (HP:0004395) | 2.30453143 |
| 52 | Abnormality of urine glucose concentration (HP:0011016) | 2.27993445 |
| 53 | Glycosuria (HP:0003076) | 2.27993445 |
| 54 | Dysostosis multiplex (HP:0000943) | 2.27686155 |
| 55 | Methylmalonic acidemia (HP:0002912) | 2.27517411 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25894491 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.25565016 |
| 58 | Mitochondrial inheritance (HP:0001427) | 2.23913244 |
| 59 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23143018 |
| 60 | Methylmalonic aciduria (HP:0012120) | 2.20987934 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.20958158 |
| 62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.20954741 |
| 63 | Progressive macrocephaly (HP:0004481) | 2.20923391 |
| 64 | Increased serum pyruvate (HP:0003542) | 2.20764142 |
| 65 | Abnormality of glycolysis (HP:0004366) | 2.20764142 |
| 66 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.18959768 |
| 67 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.18912170 |
| 68 | Abnormality of vitamin B metabolism (HP:0004340) | 2.17344745 |
| 69 | Petechiae (HP:0000967) | 2.16645973 |
| 70 | Hypothermia (HP:0002045) | 2.16247309 |
| 71 | Hypolipoproteinemia (HP:0010981) | 2.14159746 |
| 72 | Retinal atrophy (HP:0001105) | 2.13247729 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08605336 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 2.07708386 |
| 75 | Large for gestational age (HP:0001520) | 2.07500712 |
| 76 | Spastic paraparesis (HP:0002313) | 2.06826814 |
| 77 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.05937885 |
| 78 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.05859768 |
| 79 | Aplasia of the phalanges of the hand (HP:0009802) | 2.05859768 |
| 80 | Aplasia involving bones of the extremities (HP:0009825) | 2.05859768 |
| 81 | Eczematoid dermatitis (HP:0000976) | 2.05387620 |
| 82 | Fat malabsorption (HP:0002630) | 2.04824195 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.04346907 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.04346907 |
| 85 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.04016081 |
| 86 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.04016081 |
| 87 | Lethargy (HP:0001254) | 2.03812036 |
| 88 | Hyperphosphaturia (HP:0003109) | 2.03332662 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.02750169 |
| 90 | Encephalitis (HP:0002383) | 2.02379207 |
| 91 | IgG deficiency (HP:0004315) | 2.02082065 |
| 92 | Obstructive lung disease (HP:0006536) | 2.00417694 |
| 93 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00417694 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 1.99989210 |
| 95 | Tetany (HP:0001281) | 1.99937097 |
| 96 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98893125 |
| 97 | Abnormality of T cell number (HP:0011839) | 1.98744781 |
| 98 | Respiratory distress (HP:0002098) | 1.98410986 |
| 99 | Symptomatic seizures (HP:0011145) | 1.97834895 |
| 100 | Hypobetalipoproteinemia (HP:0003563) | 1.96094543 |
| 101 | Steatorrhea (HP:0002570) | 1.96044274 |
| 102 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95486686 |
| 103 | Cerebral hemorrhage (HP:0001342) | 1.95445884 |
| 104 | Recurrent abscess formation (HP:0002722) | 1.95085234 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 1.94953917 |
| 106 | Epiphyseal stippling (HP:0010655) | 1.94598339 |
| 107 | Synostosis involving the elbow (HP:0003938) | 1.94531046 |
| 108 | Humeroradial synostosis (HP:0003041) | 1.94531046 |
| 109 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92902227 |
| 110 | Mucopolysacchariduria (HP:0008155) | 1.92902227 |
| 111 | Vasculitis (HP:0002633) | 1.92828885 |
| 112 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91597273 |
| 113 | Renal cortical cysts (HP:0000803) | 1.91141111 |
| 114 | Mediastinal lymphadenopathy (HP:0100721) | 1.90922681 |
| 115 | Protuberant abdomen (HP:0001538) | 1.90736887 |
| 116 | Thyroiditis (HP:0100646) | 1.90344363 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 1.90032807 |
| 118 | Brushfield spots (HP:0001088) | 1.89867807 |
| 119 | Autoimmune hemolytic anemia (HP:0001890) | 1.89205927 |
| 120 | Nausea (HP:0002018) | 1.88285543 |
| 121 | Glomerulonephritis (HP:0000099) | 1.88227739 |
| 122 | Increased muscle lipid content (HP:0009058) | 1.87153453 |
| 123 | Anorexia (HP:0002039) | 1.86738335 |
| 124 | Hemoptysis (HP:0002105) | 1.86600599 |
| 125 | Keratoconjunctivitis (HP:0001096) | 1.86556909 |
| 126 | Abnormality of T cells (HP:0002843) | 1.86500802 |
| 127 | Abnormality of vitamin metabolism (HP:0100508) | 1.85220193 |
| 128 | Gingival bleeding (HP:0000225) | 1.84198321 |
| 129 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.84138000 |
| 130 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.84138000 |
| 131 | Increased CSF lactate (HP:0002490) | 1.83767574 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.83528298 |
| 133 | Metaphyseal dysplasia (HP:0100255) | 1.81734715 |
| 134 | Renal Fanconi syndrome (HP:0001994) | 1.81139586 |
| 135 | Pulmonary embolism (HP:0002204) | 1.81072771 |
| 136 | Onycholysis (HP:0001806) | 1.80593113 |
| 137 | T lymphocytopenia (HP:0005403) | 1.80527244 |
| 138 | Purpura (HP:0000979) | 1.80360753 |
| 139 | Vomiting (HP:0002013) | 1.80058686 |
| 140 | Gangrene (HP:0100758) | 1.79808467 |
| 141 | Urticaria (HP:0001025) | 1.79373311 |
| 142 | Abnormality of the prostate (HP:0008775) | 1.78495056 |
| 143 | Delayed CNS myelination (HP:0002188) | 1.78433302 |
| 144 | Cerebral palsy (HP:0100021) | 1.78278082 |
| 145 | Recurrent bacterial skin infections (HP:0005406) | 1.77790222 |
| 146 | Hyperglycinemia (HP:0002154) | 1.77608892 |
| 147 | Barrel-shaped chest (HP:0001552) | 1.77037741 |
| 148 | Hypokinesia (HP:0002375) | 1.76273365 |
| 149 | Epiphyseal dysplasia (HP:0002656) | 1.74003842 |
| 150 | Joint hemorrhage (HP:0005261) | 1.72735888 |
| 151 | Pancreatitis (HP:0001733) | 1.72191873 |
| 152 | Vascular calcification (HP:0004934) | 1.71769764 |
| 153 | Metabolic acidosis (HP:0001942) | 1.71075015 |
| 154 | Epidermoid cyst (HP:0200040) | 1.71041168 |
| 155 | Late onset (HP:0003584) | 1.70511594 |
| 156 | Respiratory failure (HP:0002878) | 1.70423459 |
| 157 | Paraparesis (HP:0002385) | 1.70162333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.68517660 |
| 2 | EPHB1 | 3.23590618 |
| 3 | STK39 | 2.85667655 |
| 4 | INSRR | 2.84870359 |
| 5 | TESK2 | 2.40448919 |
| 6 | ERN1 | 2.36695072 |
| 7 | IRAK3 | 2.29331775 |
| 8 | TNIK | 2.28907886 |
| 9 | MST4 | 2.18329041 |
| 10 | MAPK15 | 2.05138271 |
| 11 | MAP4K2 | 1.96955387 |
| 12 | IRAK4 | 1.96447235 |
| 13 | ACVR1B | 1.85397476 |
| 14 | MAPKAPK5 | 1.84645315 |
| 15 | PDK2 | 1.73790881 |
| 16 | RIPK4 | 1.62245093 |
| 17 | LMTK2 | 1.59938137 |
| 18 | OXSR1 | 1.58287941 |
| 19 | MAP4K1 | 1.54994707 |
| 20 | IKBKB | 1.42454390 |
| 21 | IRAK1 | 1.41975713 |
| 22 | WNK4 | 1.39375080 |
| 23 | OBSCN | 1.38568767 |
| 24 | MUSK | 1.36641963 |
| 25 | TEC | 1.35921273 |
| 26 | JAK3 | 1.35137331 |
| 27 | PBK | 1.33374569 |
| 28 | SIK1 | 1.31366799 |
| 29 | TLK1 | 1.29301918 |
| 30 | PIK3CG | 1.27502776 |
| 31 | BMPR2 | 1.24954561 |
| 32 | FGR | 1.24872232 |
| 33 | SYK | 1.24431005 |
| 34 | MET | 1.21671026 |
| 35 | MYLK | 1.21216207 |
| 36 | BCR | 1.18075454 |
| 37 | NTRK1 | 1.17053491 |
| 38 | MAP3K11 | 1.16728412 |
| 39 | ITK | 1.15932278 |
| 40 | MAPK12 | 1.15031540 |
| 41 | CLK1 | 1.14635621 |
| 42 | BMPR1B | 1.14226342 |
| 43 | MAPKAPK3 | 1.08396775 |
| 44 | ZAP70 | 1.08132923 |
| 45 | MST1R | 1.07700474 |
| 46 | TBK1 | 1.05988617 |
| 47 | GRK7 | 1.05346665 |
| 48 | TRPM7 | 1.02285697 |
| 49 | CSK | 1.00738297 |
| 50 | CAMK1D | 1.00227568 |
| 51 | FGFR4 | 1.00174121 |
| 52 | EPHA4 | 0.98343048 |
| 53 | FES | 0.97723965 |
| 54 | PINK1 | 0.94133297 |
| 55 | PDK4 | 0.93936521 |
| 56 | PDK3 | 0.93936521 |
| 57 | FGFR2 | 0.93451795 |
| 58 | NUAK1 | 0.92824280 |
| 59 | CSF1R | 0.92409152 |
| 60 | TESK1 | 0.92058711 |
| 61 | TNK2 | 0.91844043 |
| 62 | EPHA3 | 0.88123658 |
| 63 | TAOK1 | 0.88038556 |
| 64 | KDR | 0.87215365 |
| 65 | NLK | 0.86003058 |
| 66 | MATK | 0.85766009 |
| 67 | PIM2 | 0.85680003 |
| 68 | EIF2AK3 | 0.84511100 |
| 69 | PIK3CA | 0.84028651 |
| 70 | GRK5 | 0.83555636 |
| 71 | PHKG1 | 0.82620602 |
| 72 | PHKG2 | 0.82620602 |
| 73 | PRKCQ | 0.81097327 |
| 74 | TYK2 | 0.80991374 |
| 75 | PRKCE | 0.80484118 |
| 76 | MAP3K12 | 0.80256999 |
| 77 | PDPK1 | 0.80018924 |
| 78 | IRAK2 | 0.79589041 |
| 79 | MAP3K2 | 0.79461609 |
| 80 | ZAK | 0.78761524 |
| 81 | MAP3K14 | 0.78342712 |
| 82 | TXK | 0.77504516 |
| 83 | CAMK2D | 0.75641039 |
| 84 | ERBB3 | 0.75173161 |
| 85 | PKN1 | 0.73995673 |
| 86 | CASK | 0.73889508 |
| 87 | ADRBK1 | 0.73532327 |
| 88 | TIE1 | 0.73422202 |
| 89 | PRKCH | 0.70740330 |
| 90 | PRKAA2 | 0.69641709 |
| 91 | PAK3 | 0.69361289 |
| 92 | CAMK2G | 0.69030977 |
| 93 | SCYL2 | 0.68734558 |
| 94 | TGFBR2 | 0.67854268 |
| 95 | HCK | 0.67835236 |
| 96 | JAK2 | 0.67061652 |
| 97 | IKBKE | 0.66564596 |
| 98 | BTK | 0.66444271 |
| 99 | MAPK4 | 0.65201026 |
| 100 | NEK6 | 0.65167648 |
| 101 | BLK | 0.64727861 |
| 102 | MAP3K3 | 0.63939143 |
| 103 | IGF1R | 0.62220406 |
| 104 | ARAF | 0.60957222 |
| 105 | MAP2K2 | 0.60945202 |
| 106 | TRIB3 | 0.60517440 |
| 107 | CAMKK2 | 0.60298917 |
| 108 | KIT | 0.59465071 |
| 109 | AKT3 | 0.58854770 |
| 110 | JAK1 | 0.57835574 |
| 111 | FRK | 0.57450199 |
| 112 | SIK3 | 0.56511810 |
| 113 | MAP3K1 | 0.56123079 |
| 114 | ADRBK2 | 0.56099154 |
| 115 | GRK6 | 0.55389259 |
| 116 | ABL2 | 0.55115691 |
| 117 | PRKG2 | 0.54544895 |
| 118 | LIMK1 | 0.54453773 |
| 119 | LYN | 0.53015406 |
| 120 | FER | 0.52985052 |
| 121 | CAMK2A | 0.52626695 |
| 122 | CDK19 | 0.51058373 |
| 123 | TAOK3 | 0.50914737 |
| 124 | DAPK2 | 0.50901358 |
| 125 | GRK1 | 0.50816252 |
| 126 | MAP2K1 | 0.50815619 |
| 127 | LCK | 0.50719965 |
| 128 | MAP2K6 | 0.50457127 |
| 129 | CAMK1G | 0.49746304 |
| 130 | CHUK | 0.48947445 |
| 131 | SGK223 | 0.48944986 |
| 132 | SGK494 | 0.48944986 |
| 133 | PRKCZ | 0.47915514 |
| 134 | PRKCD | 0.46534710 |
| 135 | STK16 | 0.45919310 |
| 136 | MAP3K13 | 0.44231627 |
| 137 | PRKCA | 0.44230966 |
| 138 | PDK1 | 0.43333852 |
| 139 | LRRK2 | 0.41264267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.98020128 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.76469196 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.32976160 |
| 4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.78949791 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.57467506 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.54503213 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52679318 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47803402 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20533484 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.17940817 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.17492167 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.15060180 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.14231072 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.13428207 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08280588 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04519537 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.02632999 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.00521390 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.99219742 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.98771263 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86356299 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84860299 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.75288108 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72984365 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66622992 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62305085 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61358328 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54742772 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51958300 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42931716 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41632135 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41346022 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40876168 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.39547437 |
| 35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.39145991 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38432741 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37947909 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32595825 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31992300 |
| 40 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.31418969 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.31302799 |
| 42 | Proteasome_Homo sapiens_hsa03050 | 1.30847025 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.28745834 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17128177 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14312719 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13821704 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13366220 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13347100 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12606509 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08909401 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08474391 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06989732 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06570375 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04314784 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02926695 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02439876 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 1.01359411 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01008513 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00143829 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.94929396 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94077515 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91403730 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.90572859 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90103053 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90083420 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88109929 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85736539 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85613827 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82386740 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80635747 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77753121 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77657836 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.75524106 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74825351 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74724452 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74575066 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73612084 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72480714 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72282514 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72044638 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68752848 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.68599204 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67980048 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66262690 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65135850 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63951972 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62865275 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60932706 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60875953 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60255076 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60236869 |
| 92 | Bile secretion_Homo sapiens_hsa04976 | 0.58975056 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57008014 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55836846 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.55673510 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.55272591 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51648918 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50682528 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49911918 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49539963 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48825359 |
| 102 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46856707 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45932353 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44105285 |
| 105 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.43821034 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43284603 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42936720 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42469714 |
| 109 | Malaria_Homo sapiens_hsa05144 | 0.41991362 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40276043 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39469939 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34629438 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34444641 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34311907 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33001349 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.32254069 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30575836 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27098352 |
| 119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26932068 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26251291 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25341092 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24363752 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24069812 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23714000 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.23072895 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22611089 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.19880574 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.19672148 |

